← Back to Search

LARKSPUR for Chronic Pain (LARKSPUR Trial)

N/A
Waitlist Available
Led By Anthony Ong, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Access to daily internet
≥ 50 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline; at week 11 (post-intervention); at week 16 (1 month post intervention)
Awards & highlights

LARKSPUR Trial Summary

Positive Affect as a Source of Resilience for Adults in Chronic Pain

Eligible Conditions
  • Chronic Pain
  • Geriatrics

LARKSPUR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

LARKSPUR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline; at week 11 (post-intervention); at week 16 (1 month post intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline; at week 11 (post-intervention); at week 16 (1 month post intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Helpfulness, Satisfaction, and Impact as Assessed by Self-Report Participant Feedback Survey (Aim 1)
Length of Intervention Time as Measured by Number of Weeks to Complete Intervention (Aim 1)
Recruitment as Measured by Rates of Enrollment (Aim 1)
+1 more
Secondary outcome measures
Change in Depressive Symptoms as Measured by the Center for Epidemiologic Studies Depression Scale Revised (CESD-R-10) (Aim 2)
Change in FMS Pain as Measured by PROMIS Pain Intensity - Short Form 3a (Aim 2)
Change in FMS Pain as Measured by PROMIS Pain Interference - Short Form 6b (Aim 2)
+5 more
Other outcome measures
Change in Affective Reactivity to Stress as Measured by the Daily Inventory of Stressful Events (DISE)
Change in Affective Reactivity to Stress as Measured by the Daily Modified Differential Emotions Scale (mDES)

LARKSPUR Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: LARKSPUR interventionExperimental Treatment1 Intervention
Lessons in Affect Regulation to Keep Stress and Pain UndeR control
Group II: Attention Control ConditionActive Control1 Intervention
Daily emotion reporting/no intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LARKSPUR
2021
N/A
~100

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,052 Previous Clinical Trials
1,330,178 Total Patients Enrolled
16 Trials studying Chronic Pain
1,940 Patients Enrolled for Chronic Pain
National Institute on Aging (NIA)NIH
1,658 Previous Clinical Trials
28,004,354 Total Patients Enrolled
16 Trials studying Chronic Pain
2,210 Patients Enrolled for Chronic Pain
Cornell UniversityOTHER
165 Previous Clinical Trials
14,089,365 Total Patients Enrolled
5 Trials studying Chronic Pain
368 Patients Enrolled for Chronic Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~26 spots leftby Mar 2025